Arcticzymes Technologies ASA

AZT · Oslo Børs · Healthcare

19.90NOK −1.5%last day

Price as of 2 October 2026

The price over the past year, with dividends: −26.3%

Performance

1 month

−6.6%

1 year

−26.3%

3 years, per year

−12.3%

5 years, per year

−25.8%

Largest fall, 3 years

−86.4%

Below the peak now

−82.1%

Volatility, 1 year

47.4%

Return with dividends reinvested.

Key figures

P/E

65.3

P/B

3.0

Dividend yield

0.0%

Return on equity

+4.6%

Net margin

+12.7%

Market value

106 m USD

Quality, value and trend

Where Arcticzymes Technologies stands against every Nordic stock today. 100 is best.

Quality83

Profitability and a sound balance sheet over time. Better than 83% of Nordic stocks.

Value17

The price measured against earnings, assets and cash flow. Better than 17% of Nordic stocks.

Trend45

The price development over the past year. Better than 45% of Nordic stocks.

Combined44

Quality, value and trend together. Better than 44% of Nordic stocks.

About Arcticzymes Technologies

Arcticzymes Technologies ASA is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 50 employees.

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis